The one health problem of azole resistance in Aspergillus fumigatus: current insights and future research agenda

dc.creatorVerweija, Paul E.
dc.creatorLucasc, John A.
dc.creatorArendrupd, Maiken C.
dc.creatorBowyerg, Paul
dc.creatorBrinkmannh, Arjen J. F.
dc.creatorDenningi, David W.
dc.creatorDyerk, Paul S.
dc.creatorFisherl, Matthew C.
dc.creatorGeenenm, Petra L.
dc.creatorGisin, Ulrich
dc.creatorHermanno, Dietrich
dc.creatorHoogendijkq, Andre
dc.creatorLagrous, Katrien
dc.creatorMelchersa, Willem J. G.
dc.creatorRhodesl, Johanna
dc.creatorRietveldu, Anton G.
dc.creatorSchoustrav, Sijmen E.
dc.creatorStenzelp, Klaus
dc.creatorZwaanv, Bas J.
dc.creatorFraaijec, Bart A.
dc.date.accessioned2020-11-10T14:38:11Z
dc.date.available2020-11-10T14:38:11Z
dc.date.created2020
dc.description.abstractAzole resistance is a concern for the management of diseases caused by Aspergillus fumigatus in humans. Azole fungicide use in the environment has been identified as a possible cause for development of resistance, which increases the complexity and number of stakeholders involved in this emerging problem. A workshop was held in Amsterdam early 2019 in which stakeholders, including medical and agricultural researchers, representatives from the government, public health, fungicide producers and end-users, reviewed the current evidence supporting environmental selection for resistance and to discuss which research and measures are needed to retain the effectiveness of the azole class for environmental and medical applications. This paper provides an overview of the latest insights and understanding of azole resistance development in the clinical setting and the wider environment. A One Health problem approach was undertaken to list and prioritize which research will be needed to provide missing evidence and to enable preventive interventions.spa
dc.format.extent13 páginasspa
dc.format.mimetypeapplication/pdfspa
dc.identifier.doihttps://doi.org/10.1016/j.fbr.2020.10.003spa
dc.identifier.issn1749-4613spa
dc.identifier.otherhttps://doi.org/10.1016/j.fbr.2020.10.003spa
dc.identifier.urihttps://hdl.handle.net/20.500.12010/15587
dc.language.isoengspa
dc.publisherFungal Biology Reviewsspa
dc.rights.accessrightsinfo:eu-repo/semantics/openAccessspa
dc.rights.localAbierto (Texto Completo)spa
dc.sourcereponame:Expeditio Repositorio Institucional UJTLspa
dc.sourceinstname:Universidad de Bogotá Jorge Tadeo Lozanospa
dc.subjectAspergillus fumigatusspa
dc.subjectAzole resistancespa
dc.subjectDemethylase inhibitorspa
dc.subjectExpert meetingspa
dc.subjectFungicidespa
dc.subject.lembSíndrome respiratorio agudo gravespa
dc.subject.lembCOVID-19spa
dc.subject.lembSARS-CoV-2spa
dc.subject.lembCoronavirusspa
dc.titleThe one health problem of azole resistance in Aspergillus fumigatus: current insights and future research agendaspa
dc.type.coarhttp://purl.org/coar/resource_type/c_2df8fbb1spa
dc.type.hasversioninfo:eu-repo/semantics/acceptedVersionspa
dc.type.localArtículospa

Archivos

Bloque de licencias

Mostrando 1 - 1 de 1
Cargando...
Miniatura
Nombre:
license.txt
Tamaño:
2.87 KB
Formato:
Item-specific license agreed upon to submission
Descripción: